Bonsai Biotherapeutics AB
559523-4435ActiveBiotherapeutics operations assumed following major corporate merger completion.
Biotechnology Companytoleranzia.com
Översikt
- 10–19
- Anställda
- Okänt
- Omsättning
- 2025
- Grundat
Beskrivning
The organization detailed here represents the operational successor to Toleranzia AB following a formal merger with Flerie AB. This complex corporate restructuring, finalized in August 2025, involved the dissolution of Toleranzia and the transfer of all its assets and liabilities. These undertakings...
Taggar
B2BHealthTechPharmaceuticalsTechnology
Nyckelord
BiotechnologyCorporate Restructuring